Vertex Pharmaceuticals Incorporated shares owned by Norges Bank Investment Management
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Norges Bank Investment Management
from 13F filings
Historical chart of Norges Bank Investment Management investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Norges Bank Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Vertex Pharmaceuticals Incorporated by Norges Bank Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $1.6B | 3.6M | 445.20 |
| 2024-12-31 | $1.4B | 3.4M | 402.70 |
| 2024-09-30 | $1.6B | 3.4M | 465.08 |
| 2024-06-30 | $1.6B | 3.4M | 468.72 |
| 2024-03-31 | $1.4B | 3.5M | 418.01 |
| 2023-12-31 | $1.2B | 3.0M | 406.89 |
| 2023-09-30 | $930M | 2.7M | 347.74 |
| 2023-06-30 | $918M | 2.6M | 351.91 |
| 2023-03-31 | $797M | 2.5M | 315.07 |
| 2022-12-31 | $708M | 2.5M | 288.78 |
| 2022-09-30 | $663M | 2.3M | 289.54 |
| 2022-06-30 | $627M | 2.2M | 281.79 |
| 2022-03-31 | $685M | 2.6M | 260.97 |
| 2021-12-31 | $589M | 2.7M | 219.60 |
| 2021-09-30 | $458M | 2.5M | 181.39 |
| 2021-06-30 | $514M | 2.5M | 201.63 |
| 2021-03-31 | $567M | 2.6M | 214.89 |
| 2020-12-31 | $655M | 2.8M | 236.34 |
| 2020-09-30 | $779M | 2.9M | 272.12 |
| 2020-06-30 | $780M | 2.7M | 290.31 |
| 2020-03-31 | $604M | 2.5M | 237.95 |
| 2019-12-31 | $551M | 2.5M | 218.95 |
| 2019-09-30 | $404M | 2.4M | 169.42 |
| 2019-06-30 | $437M | 2.4M | 183.38 |
| 2019-03-31 | $438M | 2.4M | 183.95 |
| 2018-12-31 | $381M | 2.3M | 165.71 |
| 2018-09-30 | $448M | 2.3M | 192.74 |
| 2018-06-30 | $402M | 2.4M | 169.96 |
| 2018-03-31 | $397M | 2.4M | 162.98 |
| 2017-12-31 | $351M | 2.3M | 149.86 |
| 2017-09-30 | $327M | 2.1M | 152.04 |
| 2017-06-30 | $261M | 2.0M | 128.87 |
| 2017-03-31 | $235M | 2.2M | 109.35 |
| 2016-12-31 | $128M | 1.7M | 73.67 |
| 2016-09-30 | $140M | 1.7M | 83.30 |
| 2016-06-30 | $144M | 1.7M | 86.02 |
| 2016-03-31 | $137M | 1.7M | 79.49 |
| 2015-12-31 | $223M | 1.8M | 125.83 |
| 2015-09-30 | $184M | 1.8M | 104.14 |
| 2015-06-30 | $203M | 1.6M | 123.48 |
| 2015-03-31 | $188M | 1.6M | 117.97 |
| 2014-12-31 | $191M | 1.6M | 118.80 |
| 2014-09-30 | $173M | 1.5M | 112.31 |
| 2014-06-30 | $146M | 1.5M | 94.68 |
| 2014-03-31 | $108M | 1.5M | 70.72 |
| 2013-12-31 | $114M | 1.5M | 74.30 |
| 2013-09-30 | $144M | 1.9M | 75.82 |
| 2013-06-30 | $69M | 867k | 79.87 |
| 2013-03-31 | $36M | 662k | 54.98 |
| 2012-09-30 | $82M | 1.5M | 53.35 |
| 2012-06-30 | $39M | 798k | 48.51 |
More positions owned by Norges Bank Investment Management
View all positions for Norges Bank Investment Management
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated